Efficacy and tolerability of febuxostat in gout patients on dialysis.

See Y ChoiSeung W ChoiSunggun LeeMin W SoJi S OhDoo-Ho Lim

Published in: Internal medicine journal (2021)

Febuxostat is efficacious and well tolerated in gout patients on dialysis. Febuxostat taken at dose of 20-40 mg/day might be appropriate initial dose in patients undergoing dialysis.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
patients undergoing
ejection fraction
newly diagnosed
metabolic syndrome
patient reported